| |
| |
|
| Insider
Information: |
Burke Steven Keith |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
797,757 |
|
|
Indirect Shares
|
26,332 |
|
|
| Direct
Value |
$1,174,427 |
|
|
|
Indirect Value
|
$98,482 |
|
|
| Total
Shares |
824,089 |
|
|
| Total
Value |
$1,272,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
12
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 33.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protara Therapeutics, Inc |
TARA |
SVP and Chief Medical ... |
2019-03-15 |
101,917 |
2019-03-15 |
26,332 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2024-02-29 |
695,840 |
2019-08-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2024-02-29 |
4 |
S |
$1.58 |
$11,327 |
D/D |
(7,169) |
695,840 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2024-02-27 |
4 |
AS |
$1.52 |
$12,718 |
D/D |
(8,367) |
703,009 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2024-02-01 |
4 |
S |
$1.68 |
$40,842 |
D/D |
(24,311) |
711,376 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
202,200 |
735,687 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2023-08-25 |
4 |
S |
$1.15 |
$31,050 |
D/D |
(27,000) |
668,840 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2023-05-16 |
4 |
S |
$1.07 |
$67,890 |
D/D |
(63,567) |
530,487 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2023-03-01 |
4 |
S |
$0.88 |
$12,393 |
D/D |
(14,123) |
594,054 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2023-02-27 |
4 |
S |
$0.81 |
$6,131 |
D/D |
(7,539) |
608,177 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
196,200 |
615,716 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-08-31 |
4 |
S |
$0.36 |
$416 |
D/D |
(1,147) |
418,016 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
417,663 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-03-01 |
4 |
S |
$2.17 |
$16,619 |
D/D |
(7,656) |
217,663 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
223,819 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2022-02-28 |
4 |
S |
$2.15 |
$15,946 |
D/D |
(7,400) |
163,819 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-08-31 |
4 |
S |
$2.83 |
$2,949 |
D/D |
(1,042) |
171,219 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-04-01 |
4 |
S |
$3.40 |
$3,675 |
D/D |
(1,081) |
170,761 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,400 |
171,842 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-03-01 |
4 |
S |
$3.40 |
$25,668 |
D/D |
(7,558) |
161,442 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
169,000 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
62,000 |
99,000 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2019-11-20 |
4 |
B |
$3.58 |
$96,660 |
D/D |
27,000 |
37,000 |
0.01 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2019-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
SVP and Chief Medical Officer |
• – – |
2019-03-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
14,666 |
26,332 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
SVP and Chief Medical Officer |
• – – |
2019-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,000 |
101,917 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
SVP and Chief Medical Officer |
• – – |
2018-12-31 |
4 |
A |
$1.93 |
$4,725 |
D/D |
2,448 |
123,917 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
